Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

NCT04469179 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV2

Interventions

BIOLOGICAL: SAB-185
OTHER: Normal Saline

Sponsor

SAb Biotherapeutics, Inc.

Collaborators

[object Object]
[object Object]